Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H22N4O4S.ClH |
| Molecular Weight | 402.896 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(=O)OCC\C(SC(C)=O)=C(/C)N(CC1=CN=C(C)N=C1N)C=O
InChI
InChIKey=GVYHWIVMQYPBOQ-AZJSCORLSA-N
InChI=1S/C16H22N4O4S.ClH/c1-10(15(25-13(4)23)5-6-24-12(3)22)20(9-21)8-14-7-18-11(2)19-16(14)17;/h7,9H,5-6,8H2,1-4H3,(H2,17,18,19);1H/b15-10-;
| Molecular Formula | C16H22N4O4S |
| Molecular Weight | 366.435 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Study of diacetylthiamine (Nevriton) in current ambulatory rheumatic pathology]. | 1971-02 |
|
| [STUDIES ON THE THIAMINE METABOLISM IN GASTRECTOMIZED AND CANCER PATIENTS WITH DITHIOPROPYLTHIAMINE AND DIACETYLTHIAMINE]. | 1963-11-15 |
|
| Polarography of diacetylthiamine and dibenzoylthiamine. | 1956-03 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:50:18 GMT 2025
by
admin
on
Mon Mar 31 18:50:18 GMT 2025
|
| Record UNII |
W024X5P395
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3082278
Created by
admin on Mon Mar 31 18:50:18 GMT 2025 , Edited by admin on Mon Mar 31 18:50:18 GMT 2025
|
PRIMARY | |||
|
SUB00252MIG
Created by
admin on Mon Mar 31 18:50:18 GMT 2025 , Edited by admin on Mon Mar 31 18:50:18 GMT 2025
|
PRIMARY | |||
|
248-774-0
Created by
admin on Mon Mar 31 18:50:18 GMT 2025 , Edited by admin on Mon Mar 31 18:50:18 GMT 2025
|
PRIMARY | |||
|
100000078807
Created by
admin on Mon Mar 31 18:50:18 GMT 2025 , Edited by admin on Mon Mar 31 18:50:18 GMT 2025
|
PRIMARY | |||
|
W024X5P395
Created by
admin on Mon Mar 31 18:50:18 GMT 2025 , Edited by admin on Mon Mar 31 18:50:18 GMT 2025
|
PRIMARY | |||
|
236301
Created by
admin on Mon Mar 31 18:50:18 GMT 2025 , Edited by admin on Mon Mar 31 18:50:18 GMT 2025
|
PRIMARY | RxNorm | ||
|
m1323
Created by
admin on Mon Mar 31 18:50:18 GMT 2025 , Edited by admin on Mon Mar 31 18:50:18 GMT 2025
|
PRIMARY | Merck Index | ||
|
28008-04-0
Created by
admin on Mon Mar 31 18:50:18 GMT 2025 , Edited by admin on Mon Mar 31 18:50:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |